Screener
AngioDynamics ANGO Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Total current liabilities | 74,717 | 76,197 |
| Deferred income taxes | 5,316 | 4,073 |
| Other long-term liabilities | 16,305 | 16,904 |
| Total Liabilities | 96,338 | 97,174 |
| Commitments and Contingencies (Note 17) | ||
| Stockholders’ Equity | ||
| Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively | 387 | 385 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's total liabilities?
- AngioDynamics (ANGO) reported total liabilities of $96.34M in Q1 2026.
- How has AngioDynamics's total liabilities changed year-over-year?
- AngioDynamics's total liabilities decreased by 0.9% year-over-year, from $97.17M to $96.34M.
- What is the long-term trend for AngioDynamics's total liabilities?
- Over 5 years (2021 to 2026), AngioDynamics's total liabilities has grown at a -4.6% compound annual growth rate (CAGR), from $121.98M to $96.34M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about AngioDynamics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude